185 related articles for article (PubMed ID: 12667665)
1. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
[TBL] [Abstract][Full Text] [Related]
2. Increased intrathecal release of soluble fractalkine in HIV-infected patients.
Sporer B; Kastenbauer S; Koedel U; Arendt G; Pfister HW
AIDS Res Hum Retroviruses; 2003 Feb; 19(2):111-6. PubMed ID: 12639246
[TBL] [Abstract][Full Text] [Related]
3. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury.
Rancan M; Bye N; Otto VI; Trentz O; Kossmann T; Frentzel S; Morganti-Kossmann MC
J Cereb Blood Flow Metab; 2004 Oct; 24(10):1110-8. PubMed ID: 15529011
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
5. Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system.
Becker BF; Kastenbauer S; Ködel U; Kiesl D; Pfister HW
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1201-4. PubMed ID: 15571231
[TBL] [Abstract][Full Text] [Related]
6. Role of the urokinase plasminogen activator system in patients with bacterial meningitis.
Winkler F; Kastenbauer S; Koedel U; Pfister HW
Neurology; 2002 Nov; 59(9):1350-5. PubMed ID: 12427882
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.
Wanschitz J; Ehling R; Löscher WN; Künz B; Deisenhammer F; Kuhle J; Budka H; Reindl M; Berger T
J Neurol; 2008 Jun; 255(6):917-24. PubMed ID: 18712293
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
Yushchenko M; Weber F; Mäder M; Schöll U; Maliszewska M; Tumani H; Felgenhauer K; Beuche W
J Neuroimmunol; 2000 Oct; 110(1-2):244-51. PubMed ID: 11024556
[TBL] [Abstract][Full Text] [Related]
9. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
10. Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.
Sato E; Iikuni N; Yoshio T; Minota S; Kamatani N; Okamoto H
Ann Rheum Dis; 2006 Sep; 65(9):1257-9. PubMed ID: 16905589
[No Abstract] [Full Text] [Related]
11. The CX3C chemokine fractalkine in allergic asthma and rhinitis.
Rimaniol AC; Till SJ; Garcia G; Capel F; Godot V; Balabanian K; Durand-Gasselin I; Varga EM; Simonneau G; Emilie D; Durham SR; Humbert M
J Allergy Clin Immunol; 2003 Dec; 112(6):1139-46. PubMed ID: 14657873
[TBL] [Abstract][Full Text] [Related]
12. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
13. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
Patzold T; Sindern E; Ossege-Pohle L; Malin JP
J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
[TBL] [Abstract][Full Text] [Related]
14. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases.
Jander S; Heidenreich F; Stoll G
Neurology; 1993 Sep; 43(9):1809-13. PubMed ID: 8105425
[TBL] [Abstract][Full Text] [Related]
15. Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis.
Michel U; Ebert S; Schneider O; Shintani Y; Bunkowski S; Smirnov A; Stringaris A; Gerber J; Brück W; Nau R
Eur J Endocrinol; 2000 Dec; 143(6):809-16. PubMed ID: 11124865
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
17. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
18. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
Hasegawa M; Sato S; Echigo T; Hamaguchi Y; Yasui M; Takehara K
Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
[TBL] [Abstract][Full Text] [Related]
20. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Chiang HL; Lyu RK; Tseng MY; Chang KH; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
Clin Chim Acta; 2009 Jul; 405(1-2):143-7. PubMed ID: 19410571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
